ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Lyell Immunopharma Inc

Lyell Immunopharma Inc (LYEL)

2.61
0.07
(2.76%)
Closed May 15 4:00PM
2.61
0.00
( 0.00% )
Pre Market: 4:05AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.68M36.91M1.25M49.6M1.35M596k317k654k
Operating Income -68.58M-37.26M-66.44M-14.78M-62.56M-65.91M-59.04M-59.51M
Pre Tax Income -68.14M-36.32M-70.25M-8.4M-66.96M-63.89M-50.85M-52.93M
Net Income -68.14M-36.32M-70.25M-8.4M-66.96M-63.89M-50.85M-52.93M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -68.54M-37.28M-67.48M-12.9M-61.46M-66.23M-57.46M-60.01M
EBITDA -64.39M-33.09M-61.82M-9.74M-57.53M-60.84M-53.94M-54.45M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 657k17.19M12.97M89.44M2.92M
Operating Income -102.09M-211.94M-214.78M-187.06M-247.01M
Pre Tax Income -129.38M-204.47M-250.22M-183.12M-234.63M
Net Income -129.38M-204.47M-250.22M-183.12M-234.63M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -11.571-13.132-1.031-0.734-0.932
EBIT -137.5M-210.41M-214.94M-185.17M-245.16M
EBITDA -100.83M-207.64M-201.28M-169.04M-226.76M

Your Recent History

Delayed Upgrade Clock